Navigation Links
BioElectronics Corporation's Commercial Resumes on Bloomberg Television
Date:7/15/2008

ActiPatch(TM) Brand and Product Awareness On the Increase

FREDERICK, Md., July 15 /PRNewswire-FirstCall/ -- BioElectronics Corporation, (Pink Sheets: BIEL), announced today that the company will resume airing an investment and product-related commercial on financial network Bloomberg Television. CEO of BioElectronics, Andrew Whelan says, "We previously ran this commercial in April with significant success relating both to our equity and product awareness. We are excited to see these commercials airing again today and reaching millions of people."

ActiPatch(TM), the product marketed by BioElectronics Corp. is changing the face of medicine and the way we heal. Recently chosen as "One of 9 Medical Breakthroughs That May Change Your Life," by MedicalHeadway.com, ActiPatch(TM) is fast becoming the treatment of choice for everything from soft tissue injuries to surgical recovery.

ActiPatch(TM) is a drug-free wafer thin patch with an embedded battery- operated microchip that delivers weeks of continuous pulsed RF therapy for less than a dollar a day. The unique ActiPatch(TM) delivery system, using patented technology, provides a cost-effective, home use method that reduces soft tissue pain and swelling, and accelerates healing.

ActiPatch(TM) is very thin, easily applied and comfortable to wear on an injured area. The patch effectively minimizes pain and swelling. Physicians are so impressed with the power of the patch that they are providing it to their patients for uses beyond plastic surgery recovery.

Distribution has expanded into Canada, Italy, Switzerland, Denmark, Scandinavian countries, Singapore, Malaysia and India.

For more information visit http://www.bioelectronicscorp.com or call 866-757-2284.

About BioElectronics Corporation

BioElectronics Corporation is the maker of the ActiPatch(TM). ActiPatch(TM) is a drug-free anti-inflammatory
'/>"/>

SOURCE BioElectronics Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. BioElectronics Corporation Receives 2007 Economic Development Innovator of the Year Award
2. BioElectronics Corporation Announces Addition of Michael Seidenman, R.Ph. as Vice President of Sales
3. BioElectronics Corporation (BIEL) SqueezeTrigger Price is $0.11
4. BioElectronics Corporations New Commercial Airing Nationally Advertising Initiative Will Reach 15,000,000 Homes Nationwide
5. BioElectronics CEO Andrew Whelan: Positioning the Company for Growth During 2008 and Beyond
6. BioElectronics Corporation Announces New Website for Italian Market
7. Nationally Recognized Corporations and Retailers Rally Behind breastcancer.org
8. BDSI secures US commercial partnership for BEMA Fentanyl with Meda AB
9. WellPoint and M-Plan Enter Into Endorsement Agreement as M-Plan Announces Exit From the Commercial HMO Business in Indiana
10. Pathway Diagnostics Announces Commercial Availability of SensiTrop(TM) HIV Co-receptor Tropism Assay
11. OmniGuide Begins European Commercialization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... University College of Medicine research team led ...ayer of regulation in the cell division cycle, whi...y cancer begins. , Wang, an assistant professor ... said the findings will lead to an improved abilit...of new drugs that kill cancer cells by inhibiting ...
(Date:11/21/2008)...wswire/ -- The Generic,Pharmaceutical Association...m,GPhA President and CEO Kathleen Jaeger regardin...n "Emerging Health Care Competition and Consumer I...nducting this roundtable demonstrates the,growing...ss to safe and,affordable biogenerics sooner rath...
(Date:11/21/2008)...SNewswire/ -- New research at West Virginia Unive...tobacco product aimed at young adults is catching ...s, Camel Snus - touted as a socially acceptable wa...h levels of nicotine. , , "Camel Snus conta... said Bruce Adkins of the state Division of Tobacc...
(Date:11/21/2008)...e-FirstCall/ -- Today, prescription drugs are the ...88 percent of patients suffering chronic condition...nic condition account for 96 percent of all prescr... costs. A proprietary new pharmacy model develope... (NYSE: MHS ) significantly reduces critical gap...
Breaking Medicine News(10 mins):Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6
...s all for a giving a boost to herbal plants.While ...o, tomato and green vegetables// at their official...ource centre for herbal farming. Nitish Kumar com...bal background. His father was a leading ayurvedic...
...innamon odors can increase alertness and decrease ... undergraduate student, has conducted this interes...r, Dr. Bryan Raudenbush, Wheeling Jesuit Universit...oth cinnamon and peppermint increased alertness an...
...O), there is an outbreak of apparent botulism, whi...ed// bamboo shoots. It has left more than 150 peo...further stated that according to the Thai Ministry...s and symptoms consistent with botulism as on Marc...
...000 men aged 16 to 59, it was found that men who...%// more likely to be impotent than non-smokers. ...nth or more in the previous year. Those who smoked... more likely to report impotence problems. Anti-sm...
Other Medicine News:Health News:Bamboo Shoots Causes Botulism Outbreak 2Health News:Smoking Is a Vital Cause among Impotent Men 2
(Date:11/19/2008)... , Study did not achieve statistical significa...FirstCall/ -- Pharmos Corporation (Nasdaq: PARS ...al trial of its topical NanoEmulsion (NE) drug del...thanolamine. , , The multi-center, randomiz...ated the safety and efficacy of the Company,s 3% D...
(Date:11/19/2008)...K, Del., Nov. 19 Isogen, a contrac...sterile filling, today announced the first,phase ...n was founded to,specifically address the process...ted with the $2 billion highly-niched, low-volume ...ng market segment. , Companies can invest o...
(Date:11/18/2008)... www.christmasseals.org to learn more, make a do... WASHINGTON, Nov. 17 Mi...is month, courtesy of the American Lung Associatio...annual fundraising tradition dating back to 1907 w...berculosis. , , "Most Americans alive tod...
(Date:11/18/2008)...can Lung Association,s 2008 Faces of Influenza sur...immunized against influenza; Mother and Gold Medal...WASHINGTON, Nov. 18 While 78 perce...nza a severe and potentially life-threatening dise...kely their families will get vaccinated this seaso...
Breaking Medicine Technology:Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Isogen Launches Major New Facility to Address Global Biopharma Demand 2American Lung Association Celebrates 101st Annual Christmas Seals Campaign 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6Highmark Medicare Services Achieves Certification to COPC 2000 28R 29 CSP Standard 18403 1Highmark Medicare Services Achieves Certification to COPC 2000 28R 29 CSP Standard 18403 2Highmark Medicare Services Achieves Certification to COPC 2000 28R 29 CSP Standard 18403 3Celebrity Mothers and Daughters Including Miley and Trish Cyrus Join Swarovski to Support Breast Cancer Survivors 18401 1Celebrity Mothers and Daughters Including Miley and Trish Cyrus Join Swarovski to Support Breast Cancer Survivors 18401 2HealthMedia 28R 29 Explosive Growth Continues in First Quarter 2008 18399 1HealthMedia 28R 29 Explosive Growth Continues in First Quarter 2008 18399 2HealthMedia 28R 29 Explosive Growth Continues in First Quarter 2008 18399 3Study Suggests Stronger Tobacco Control Policies in States With High Smoking Rates Would be Effective in Reducing Smoking and Saving Thousands of Live 18397 1Study Suggests Stronger Tobacco Control Policies in States With High Smoking Rates Would be Effective in Reducing Smoking and Saving Thousands of Live 18397 2Study Suggests Stronger Tobacco Control Policies in States With High Smoking Rates Would be Effective in Reducing Smoking and Saving Thousands of Live 18397 3
...noMed (OTC Pink,Sheets:GMED), the Next Generation ...c health(TM), announced today publication of a,cas...isappeared for,over a year thanks to GenoMed,s tre...ican woman who for,years required multiple pain pi...ell disease. Since beginning GenoMed,s trial on De...
...irstCall/ --,InB:Biotechnologies, Inc. ("BioTech")...a, Inc. , today announced strong positive,results ...ague made,using INBP,s novel, proprietary AIPwLV(T...by the Fraunhofer USA Center for Molecular,Biotech...ed by Dr.,Vidadi Yusibov, through which BioTech ex...
Other Medicine Technology:GenoMed Prevents Sickle Cell Pain for Over a Year 2Integrated Biopharma's Proprietary Vaccine Technology Achieves,Strong Positive Results 2
Freer elevator, double end, 7 1/4", S/B.
The Surgifoam* absorbable gelatin sponge, U.S.P. is a sterile, water-insoluble, malleable, porcine gelatin absorbable sponge intended for hemostatic use by applying to a bleeding surface. The sponge
The Surgifoam* absorbable gelatin sponge, U.S.P. is a sterile, water-insoluble, malleable, porcine gelatin absorbable sponge intended for hemostatic use by applying to a bleeding surface. The sponge
16 mm diameter curved probes with suture eyes just back of blunt ends. Stainless steel. Round knurled handle with polished finish. Overall length: 5.7 inches.
Medicine Products: